Latest KFF Health News Content

Latest KFF Health News Stories

Failure To Find Source Of E. Coli Outbreak Highlights Vulnerabilities In Food Safety Regulation

Morning Briefing

As the outbreak enters its second month, investigators are still scrambling to locate its origin. In other public health news: domestic violence, Alzheimer’s, anti-depression medication, eyeglasses, Lyme disease, autism, and more.

Ohio Refuses To Consider Medicaid Change That Saved West Virginia Millions Of Dollars

Morning Briefing

The model would require the state to get rid of managed care in favor of the state university handling benefits for Medicaid recipients. But Ohio says the move would cost more money than it would save. Medicaid news comes out of Iowa and Connecticut, as well.

A Veritable Who’s-Who Of High-Profile Investors Lost Big In Theranos Debacle

Morning Briefing

Education Secretary Betsy DeVos, whose family invested $100 million in the blood-testing start-up, is just one of the well-known investors that took a chance on what was touted as a Silicon Valley fairy tale.

Two Drug Epidemics, Decades Apart: Why Government’s Response To Opioid Epidemic Different Than Crack Crisis

Morning Briefing

Many see race as a crucial factor in how Congress and health officials have focused on prevention and education rather than punishment. White victims make up almost 80 percent of the deaths from opioid overdoses, while, in contrast, in 2000, 84 percent of crack cocaine offenders were black. In other news on the crisis: a 25-year-old pill for nerve pain raises some red flags; the DEA issues an immediate suspension of opioid sales by a wholesale distributor; drug distributors head to Capitol Hill; and more.

‘We’ve Been Planning For It’: FDA Braced For Tsunami Of Retirements From Its Senior Level Staff

Morning Briefing

FDA Commissioner Scott Gottlieb emphasized the need to cut hiring time when it comes to rank-and-file staff positions. At the annual meeting of the Reagan-Udall Foundation for the FDA, Gottlieb also countered criticism of the agency’s “breakthrough” designation for certain drugs.

VA Has Been ‘Hemorrhaging’ Career Officials And Doctors For Months As Chaos Ripples Throughout Agency

Morning Briefing

“I’ve never known the enthusiastic mass exodus of an organization’s most knowledgeable and experienced personnel to be an indication that all is well,” said John Hoellwarth, a spokesman for Amvets. The VA has been struggling with its leadership at the same time there’s been a push to move toward privatization, and the officials on the ground are overwhelmed and understaffed.

IRS Aggressively Enforcing Employer Mandate Despite Trump’s Promise That Health Law Is All But Dead

Morning Briefing

Business groups want relief from the mandate, but lawmakers have little appetite to take up any more changes in this politically charged election year. Meanwhile, Idaho officials are still trying to figure out ways to sell plans that don’t comply with health law regulations.

‘Pharma Folks Are Nervous’ As Trump Gears Up For Major Speech On Curbing Drug Prices

Morning Briefing

This week’s planned speech is expected to offer a “comprehensive strategy” that administration officials say will result in a “profound modernization” of how the government pays for some drugs. But the pharma industry is watching anxiously in case President Donald Trump goes off script.

In Search Of Migraine Treatments, Genetic Researchers Trace Variations Through Families

Morning Briefing

Scientists studying families with migraines find evidence that hundreds of genetic variants can determine the symptoms and severity of the debilitating disease. In other public health news today: brain implants, the CDC’s disease detective program, brain trauma, breast cancer and menopause.